Why are IMFINZI + enfortumab vedotin (EV) given together to help treat MIBC?

IMFINZI + EV

IMFINZI works together with your immune system and EV, a targeted cancer medicine, to help find and attack cancer cells before surgery. This is called neoadjuvant therapy.

Surgery

Doctors typically recommend surgery to remove the bladder.

IMFINZI

IMFINZI is given alone to continue fighting leftover cancer cells after surgery. This is called adjuvant therapy.

How are IMFINZI and EV given to treat MIBC?

It can be helpful to think of treatment for MIBC as a journey in 3 steps. Here’s an overview about what to expect:

IMFINZI + enfortumab vedotin (EV)

Your care team will recommend starting your treatment with IMFINZI + EV as a first step before surgery. You’ll receive IMFINZI together with EV every 3 weeks for 3 cycles.

You and your care team will talk about how to prepare for surgery and your urinary diversion options (these are different ways of going to the bathroom).

Your doctor will test your blood for certain side effects. Your healthcare provider may treat your side effects with other types of medicine. They may delay or stop treatment if you have side effects that are too difficult to manage, or they may stop treatment if your cancer gets worse.

How is IMFINZI given?

at your doctor’s office

or at an infusion center

as an intravenous (IV) infusion

for about 60 minutes per infusion

Helpful resources for you to use

IMFINZI Patient Guide

Have the facts at your fingertips by downloading a complete brochure—from information about MIBC to helpful tips to support your treatment.

Download the guide

Side Effects Tracker

Track side effects during treatment with IMFINZI to help guide easier conversations with your doctor.

Download the tracker

Frequently Asked Questions

Expand all
Collapse all

MIBC stands for muscle-invasive bladder cancer. In MIBC, cancer cells spread into or through the muscle layer of the bladder wall.

IMFINZI + EV is for people who have muscle-invasive bladder cancer that has spread into the muscle layer of the bladder but not to other parts of the body who cannot receive or refuse cisplatin-based chemotherapy.

When cancer cells appear in your body, your immune system works to recognize and attack them.

Programmed death‑ligand 1 (PD-L1) is a protein that disguises cancer cells from the immune system.

IMFINZI works by binding to and blocking PD-L1 to remove the disguise, so, your immune system is better able to find and attack these cancer cells. IMFINZI may affect healthy cells during or after treatment, too.

EV is a targeted cancer treatment that travels through the body to identify and attach to cancer cells and then delivers the cancer-killing medicine to them.

EV may also affect healthy cells.

Before surgery, IMFINZI is given by infusion on Day 1 every 3 weeks for 3 cycles. EV is given by infusion twice every 3 weeks (Day 1 and Day 8) for 3 cycles. Each cycle is 21 days.

After surgery, IMFINZI is given by infusion every 4 weeks for up to 9 cycles, or as long as your doctor recommends.

While on IMFINZI, you may experience side effects. This is because IMFINZI works with your immune system to treat cancer, which can also affect the way normal organs and tissues work. These problems can sometimes become serious or life-threatening and can lead to death in some cases. You can have more than one of these problems at the same time. These problems may happen anytime during treatment or even after your treatment has ended.

IMFINZI may cause serious side effects. They include:

  • Lung problems
  • Intestinal problems
  • Liver problems
  • Hormone gland problems
  • Kidney problems
  • Skin problems
  • Pancreas problems
  • Problems in other organs and tissues
  • Severe infusion reactions
  • Rejection of a transplanted organ or tissue
  • Complications, including graft-versus-host disease (GVHD), in people who have received a bone marrow (stem cell) transplant that uses donor stem cells (allogeneic)

Getting medical treatment right away may help keep these problems from becoming more serious. Your healthcare provider will check you for these problems during your treatment with IMFINZI. Your healthcare provider may treat you with corticosteroid or hormone replacement medicines. Your healthcare provider may also need to delay or completely stop treatment with IMFINZI, if you have severe side effects.

The most common side effects of IMFINZI when used with enfortumab vedotin-ejfv (EV) in adults with muscle-invasive bladder cancer (MIBC) include:

  • increased liver function tests
  • decreased red blood cells
  • rash
  • increased level of creatinine in the blood
  • itching
  • decreased level of calcium in the blood
  • increased level of lipase in the blood
  • increased level of potassium in the blood
  • urinary tract infection
  • increased level of amylase in the blood
  • feeling tired
  • decreased level of sodium in the blood
  • decreased white blood cell counts
  • diarrhea
  • constipation
  • decreased appetite
  • changes in the way foods taste or loss of taste
  • nausea
  • inflammation of the nerves causing numbness, weakness, tingling or burning pain of the arms and legs
  • muscle and joint pain
  • hair loss

Tell your doctor if you have any side effect that bothers you or that does not go away. These are not all the possible side effects of IMFINZI. Please see full Important Safety Information below and Full Prescribing Information, including Medication Guide for IMFINZI.

IMPORTANT SAFETY INFORMATION

What is the most important information I should know about IMFINZI® (durvalumab)?

IMFINZI is a medicine that may treat certain cancers by working with your immune system. IMFINZI can cause your immune system to attack normal organs and tissues in any area of your body and can affect the way they work. These problems can sometimes become severe or life-threatening and can lead to death. You can have more than one of these problems at the same time. These problems may happen anytime during treatment or even after your treatment has ended.

Call or see your healthcare provider right away if you develop any new or worsening signs or symptoms, including:

What is IMFINZI?

IMFINZI may be used in combination with enfortumab vedotin-ejfv (EV) (neoadjuvant treatment) prior to surgical removal of your bladder followed by IMFINZI alone after surgery (adjuvant treatment) to treat a type of bladder cancer called muscle-invasive bladder cancer (MIBC) that has spread into the muscle layer of the bladder but not to other parts of the body and if you cannot receive or have decided not to receive cisplatin-based chemotherapy.

It is not known if IMFINZI is safe and effective in children.

 

 

  • ISI Lungs Problem Symptoms

    Lung problems: cough, shortness of breath, and chest pain

  • ISI Intestinal Problem Symptoms

    Intestinal problems: diarrhea (loose stools) or more frequent bowel movements than usual; stools that are black, tarry, sticky, or have blood or mucus; and severe stomach-area (abdomen) pain or tenderness

  • ISI Liver Problem Symptoms

    Liver problems: yellowing of your skin or the whites of your eyes, severe nausea or vomiting, pain on the right side of your stomach area (abdomen), dark urine (tea colored), and bleeding or bruising more easily than normal

  • ISI Hormonal Gland Symptoms

    Hormone gland problems: headaches that will not go away or unusual headaches; eye sensitivity to light; eye problems; rapid heartbeat; increased sweating; extreme tiredness; weight gain or weight loss; feeling more hungry or thirsty than usual; urinating more often than usual; hair loss; feeling cold; constipation; your voice gets deeper; dizziness or fainting; and changes in mood or behavior, such as decreased sex drive, irritability, or forgetfulness

  • ISI Kidney Problem Symptoms

    Kidney problems: decrease in your amount of urine, blood in your urine, swelling of your ankles, and loss of appetite

  • ISI Skin Problem Symptoms

    Skin problems: rash; itching; skin blistering or peeling; painful sores or ulcers in mouth or nose, throat, or genital area; fever or flu-like symptoms; and swollen lymph nodes

  • ISI Pancreas Problem Symptoms

    Pancreas problems: pain in your upper stomach area (abdomen), severe nausea or vomiting, and loss of appetite

  • ISI Other Organ Problem Symptoms

    Problems can also happen in other organs and tissues. These are not all of the signs and symptoms of immune system problems that can happen with IMFINZI. Call or see your healthcare provider right away for any new or worsening signs or symptoms, which may include: Chest pain, irregular heartbeats, shortness of breath or swelling of ankles; confusion, sleepiness, memory problems, changes in mood or behavior, stiff neck, balance problems; tingling, numbness or weakness of the arms or legs; double vision, blurry vision, sensitivity to light, eye pain, changes in eye sight; persistent or severe muscle pain or weakness, muscle cramps, joint pain, joint stiffness or swelling; and low red blood cells and bruising

  • ISI Infusion Reaction Signs and Symptoms

    Infusion reactions that can sometimes be severe or life-threatening. Signs and symptoms of infusion reactions may include: chills or shaking, itching or rash, flushing, shortness of breath or wheezing, dizziness, feel like passing out, fever, and back or neck pain

  • ISI Organ or Tissue Transplant Rejection

    Rejection of a transplanted organ or tissue. Your healthcare provider should tell you what signs and symptoms you should report and monitor you depending on the type of organ or tissue transplant that you have had

  • ISI Transplant Complications Symptoms

    Complications, including graft-versus-host disease (GVHD), in people who have received a bone marrow (stem cell) transplant that uses donor stem cells (allogeneic). These complications can be serious and can lead to death. These complications may happen if you underwent transplantation either before or after being treated with IMFINZI. Your healthcare provider will monitor you for these complications

Getting medical treatment right away may help keep these problems from becoming more serious. Your healthcare provider will check you for these problems during your treatment with IMFINZI. Your healthcare provider may treat you with corticosteroid or hormone replacement medicines. Your healthcare provider may also need to delay or completely stop treatment with IMFINZI if you have severe side effects

Before you receive IMFINZI, tell your healthcare provider about all of your medical conditions, including if you:

  • have immune system problems such as Crohn's disease, ulcerative colitis, or lupus
  • have received an organ or tissue transplant, including corneal transplant
  • have received or plan to receive a stem cell transplant that uses donor stem cells (allogeneic)
  • have received radiation treatment to your chest area
  • have a condition that affects your nervous system, such as myasthenia gravis or Guillain-Barré syndrome
  • are pregnant or plan to become pregnant. IMFINZI can harm your unborn baby
    • Females who are able to become pregnant:

    • Your healthcare provider will give you a pregnancy test before you start treatment with IMFINZI.
    • You should use an effective method of birth control during your treatment and for 3 months after the last dose of IMFINZI.
      Talk to your healthcare provider about birth control methods that you can use during this time.
    • Tell your healthcare provider right away if you become pregnant or think you may be pregnant during treatment with IMFINZI.
  • are breastfeeding or plan to breastfeed. It is not known if IMFINZI passes into your breast milk. Do not breastfeed during treatment and for 3 months after the last dose of IMFINZI.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

What are the possible side effects of IMFINZI?

IMFINZI can cause serious side effects (see above).

The most common side effects of IMFINZI when used with enfortumab vedotin-ejfv (EV) in adults with muscle-invasive bladder cancer (MIBC) include increased liver function tests, decreased red blood cells, rash, increased level of creatinine in the blood, itching, decreased level of calcium in the blood, increased level of lipase in the blood, increased level of potassium in the blood, urinary tract infection, increased level of amylase in the blood, feeling tired, decreased level of sodium in the blood, decreased white blood cell counts, diarrhea, constipation, decreased appetite, changes in the way foods taste or loss of taste, nausea, inflammation of the nerves causing numbness, weakness, tingling or burning pain of the arms and legs, muscle and joint pain, and hair loss.

Tell your healthcare provider if you have any side effect that bothers you or that does not go away. These are not all the possible side effects of IMFINZI. Ask your healthcare provider or pharmacist for more information.

Call your doctor for medical advice about side effects. You may report side effects related to AstraZeneca productsReport side effects related to AstraZeneca products. If you prefer to report these to the FDA, either visit www.FDA.gov/medwatch or call 1-800-FDA-1088.

Call your doctor for medical advice about side effects. You may report side effects related to AstraZeneca productsReport side effects related to AstraZeneca products. If you prefer to report these to the FDA, either visit www.FDA.gov/medwatch or call 1-800-FDA-1088.

Please see Full Prescribing Information including Medication Guide for IMFINZI.

What is IMFINZI?

IMFINZI may be used in combination with enfortumab vedotin-ejfv (EV) (neoadjuvant treatment) prior to surgical removal of your bladder followed by IMFINZI alone after surgery (adjuvant treatment) to treat a type of bladder cancer called muscle-invasive bladder cancer (MIBC) that has spread into the muscle layer of the bladder but not to other parts of the body and if you cannot receive or have decided not to receive cisplatin-based chemotherapy.

It is not known if IMFINZI is safe and effective in children.

Please see Full Prescribing Information including Medication Guide for IMFINZI.

Minimize

Important Safety Information

What is the most important information
I should know about IMFINZI® (durvalumab)?

IMFINZI is a medicine that may treat certain cancers by working with your immune system. IMFINZI can cause your immune system to attack normal organs and tissues in any area of your body and can

IMFINZI is a medicine that may treat certain cancers by working with your immune system.

Read full Important Safety Information

What is IMFINZI?

IMFINZI may be used in combination with enfortumab vedotin-ejfv (EV) (neoadjuvant treatment) prior to surgical removal of your bladder followed by IMFINZI alone after surgery (adjuvant treatment) to treat a type of bladder cancer called muscle-invasive bladder cancer (MIBC) that has spread into